A prospective single-center randomized controlled clinical study of Pseudomonas aeruginosa injection (Vantepuan ®) combined with PD-1 monoclonal antibody and chemotherapy in first-line treatment of patients with advanced non-small cell lung cancer

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: 215ad4e4264d896b25e4797a6b0670535eee4299
First added on: Apr 08, 2025